FDA Approved: TIVICAY PD — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA issued a supplemental approval for Tivicay PD (dolutegravir) from ViiV Healthcare, adding/changing the pediatric formulation for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TIVICAY PD (dolutegravir sodium)

Snippet

SUPPL AP for TIVICAY PD (DOLUTEGRAVIR SODIUM)